Dr. Serge Charbel Harb, MD

Dr. Harb practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Harb's NPI, 1841502267, was assigned on July 14, 2010. Dr. Harb holds Ohio license 35.099950.

Dr. Harb's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Harb's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Harb is also affiliated with Fairview Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Harb to 1 more hospital, 2 clinical labs and 2 medical groups, each named with a free account. Dr. Harb's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harb practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Harb's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Harb is licensed in Ohio.

CMS data shows 1,390 Medicare services from Dr. Harb across 26 procedure codes in 2024, for 787 Medicare patients. Medicare paid $62,406 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 787 Medicare patients who saw Dr. Harb in 2024. The largest group is 65 to 74, with 345 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Harb's median patient age at 65, with 42% women.

In 2024, Dr. Harb wrote 366 Medicare Part D claims for 76 patients. 84% of them were for generic drugs. CMS names the drug for 262 of them, across 12 drugs with 11 or more claims each, at $62,445 in total drug cost. In 2023, CMS named 309 claims across 11 drugs.

Dr. Harb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Harb as offering telehealth.

Dmand AI links 186 papers to Dr. Harb, published from 2011 to 2025. 2023 was the busiest year, with 25. The most frequent topics are Heart Valve Prosthesis Implantation, Aortic Valve Stenosis and Cardiac Catheterization. Dr. Harb has published most often in Am J Cardiol. Dr. Harb's most frequent co-authors are Rishi Puri, MD, PhD, Grant William Reed, MD, MS and Wael A. Jaber, MD.

Dmand AI links Dr. Harb to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Tricuspid Valve Insufficiency, Gastroesophageal Reflux and Mitral Valve Insufficiency. Edwards Lifesciences sponsors the most, 3.

CMS Open Payments shows 192 general payments to Dr. Harb from 10 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 56% of the total. Edwards Lifesciences Corporation paid the most, $55,714.